Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DIMS0150

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND The Toll-like-receptor 9 (TLR-9) agonist cobitolimod (DIMS0150, Kappaproct®) is a promising therapeutic option for… Expand
Is this relevant?
2017
2017
s of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation S117 that both genotype and phenotype influenced the… Expand
  • table 1
  • table 2
Is this relevant?
2016
2016
BACKGROUND AND AIMS Toll-like receptors [TLRs] are potential drug targets for immunomodulation. We determined the safety and… Expand
Is this relevant?
2014
2014
BackgroundGlucocorticoids (GCS) remain one of the mainstay treatments in the management of ulcerative colitis (UC) but up to a… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2014
2014
Background and aim: The Toll like receptor 9 (TLR9) has over the years received growing interest as a potential point of… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2013
2013
BACKGROUND Patients with chronic active ulcerative colitis (UC) are regarded as treatment failures and represent an area of high… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?